Abstract
Cancer is a major cause of death worldwide despite significant advances in surgery and biology. Several recent studies have suggested that there is a close connection between tumorigenesis and inflammation. Cyclooxygenase-2 (COX-2), a link between inflammation and cancer, was proposed as a prime target for cancer therapy. However, the main available COX-2 inhibitors, nonsteroidal antiinflammatory drugs (NSAIDs), have several side effects that limit their application in cancer treatment. Additional research is needed to identify drugs that can regulate COX-2 or prostaglandin E2 (PGE2) with greater efficacy. Understanding the mechanism of COX-2/PGE2-mediated cancer and inflammation would be very useful for successful drug development. Progress of research and development into the role of COX related signaling both in inflammation and tumorigenesis in recent years has been summarized and introduced in this paper. Novel drugs designed to inhibit COX-2-related cancers are discussed to provide references for further development of novel drugs.
Keywords: Cancer, COX-2, Cyclooxygenase, Inflammation, Oncology, PGE2.
Mini-Reviews in Medicinal Chemistry
Title:Influencing COX-2 Activity by COX Related Pathways in Inflammation and Cancer
Volume: 16 Issue: 15
Author(s): Tingting Yu, Xingzhen Lao and Heng Zheng
Affiliation:
Keywords: Cancer, COX-2, Cyclooxygenase, Inflammation, Oncology, PGE2.
Abstract: Cancer is a major cause of death worldwide despite significant advances in surgery and biology. Several recent studies have suggested that there is a close connection between tumorigenesis and inflammation. Cyclooxygenase-2 (COX-2), a link between inflammation and cancer, was proposed as a prime target for cancer therapy. However, the main available COX-2 inhibitors, nonsteroidal antiinflammatory drugs (NSAIDs), have several side effects that limit their application in cancer treatment. Additional research is needed to identify drugs that can regulate COX-2 or prostaglandin E2 (PGE2) with greater efficacy. Understanding the mechanism of COX-2/PGE2-mediated cancer and inflammation would be very useful for successful drug development. Progress of research and development into the role of COX related signaling both in inflammation and tumorigenesis in recent years has been summarized and introduced in this paper. Novel drugs designed to inhibit COX-2-related cancers are discussed to provide references for further development of novel drugs.
Export Options
About this article
Cite this article as:
Yu Tingting, Lao Xingzhen and Zheng Heng, Influencing COX-2 Activity by COX Related Pathways in Inflammation and Cancer, Mini-Reviews in Medicinal Chemistry 2016; 16 (15) . https://dx.doi.org/10.2174/1389557516666160505115743
DOI https://dx.doi.org/10.2174/1389557516666160505115743 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Biodiversity, Ethnopharmacology, Biotechnology, Bioclimatology and Scientific Education Applied to Toxicology and One Health
Neglected Tropical Diseases (NTDs) are represented by a group of distinct illnesses that affect the most vulnerable segment of the population, negatively impacting the Economy and Public Health. For example, like snakebite, leishmaniasis disproportionately affects vulnerable populations in tropical and subtropical regions. The search for safe drugs against various diseases ...read more
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Chemistry of Materials and Emerging Techniques: Future of Drug Discovery and Medicinal Product Developments
In drug discovery, established knowledge of functional groups, their chemical behaviors, and structure-activity relationships favor chemists to achieve desired efficacy and safety profiles within the novel designed medicinal products. Here, judicious integration of different tools and techniques of chemistry also plays a fundamental role towards the selection of the processes ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Human Milk has Anti-Oxidant Properties to Protect Premature Infants
Current Pediatric Reviews Endogenous Ethanol-producing Bacteria Interference in Pathogen-host Crosstalk
Endocrine, Metabolic & Immune Disorders - Drug Targets Study of Prolactin Permeation Through the Pericardium and Its Bioavailability
Protein & Peptide Letters Hormone-Dependent Regulation of Renin and Effects on Prorenin Receptor Signaling in the Collecting Duct
Current Hypertension Reviews The Safety, Efficacy and Therapeutic Potential of Histone Deacetylase Inhibitors with Special Reference to Panobinostat in Gastrointestinal Tumors: A Review of Preclinical and Clinical Studies
Current Cancer Drug Targets Plasmodium Dihydroorotate Dehydrogenase: A Promising Target for Novel Anti-Malarial Chemotherapy
Infectious Disorders - Drug Targets Functionalized Organolithium Compounds: New Synthetic Adventures
Current Organic Chemistry Intracellular Delivery of Potential Therapeutic Genes: Prospects in Cancer Gene Therapy
Current Gene Therapy Mesangial Cells and Glomerular Inflammation: From the Pathogenesis to Novel Therapeutic Approaches
Current Drug Targets - Inflammation & Allergy Inflammasomes as Potential Therapeutic Targets in Atherosclerotic Cardiovascular Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets Identification of New Targets for Therapy of Osteolytic Bone Disease in Multiple Myeloma
Current Drug Targets Cysteinyl Leukotrienes (CysLTs): Role in Obesity-Induced Asthma
Current Molecular Medicine Selenium and Cardiovascular Surgery: An Overview
Current Drug Safety The Immunomodulatory Role of Vitamin D in Respiratory Diseases
Current Respiratory Medicine Reviews Approaches to the Management of Acute Kidney Injury in Children
Recent Patents on Biomarkers Editorial: Neurobiological Consequences of Oxidative Stress.
Current Neuropharmacology Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide-Induced Immunomodulation of T and NK Cell Function
Current Cancer Drug Targets Pharmacokinetics and Systemic Activity of a New Patent of an Inhaled Corticosteroid/Long-Acting β2-Agonist Combination for Use in Asthma Therapy: Fluticasone Furoate/Vilanterol Trifenatate
Recent Patents on Inflammation & Allergy Drug Discovery Covid-19: An Update on Clinical Features, Diagnosis, and Treatment Strategies
Coronaviruses Vessel Graft Atherosclerosis in Murine Models
Current Drug Targets